Clinical Trials in Barletta, Italy
6 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
Relapsed or Refractory Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS122 enrolled32 locationsNCT05300282
Recruiting
Not Applicable
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
Classical Hodgkin LymphomaDiffuse Large B-Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS552 enrolled40 locationsNCT05934084
Recruiting
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
Non-hodgkin Lymphoma,B Cell
Fondazione Italiana Linfomi - ETS1,500 enrolled61 locationsNCT06008691
Recruiting
Financial Toxicity (FT) for Radiotherapy (RT) Patients in Italy: a yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica) Multicenter Study
Oncologic Diseases
Valerio Nardone1,000 enrolled7 locationsNCT07175350
Recruiting
DOsimetry and Radiation Induced NAusea in Head and Neck Cancers
Head and Neck Cancer
European Institute of Oncology180 enrolled14 locationsNCT06341985
Recruiting
BRING-UP 3 Heart Failure
Heart Failure
Heart Care Foundation10,000 enrolled187 locationsNCT06279988
Recruiting
BRING-UP Prevention
Peripheral Arterial DiseaseCerebrovascular DisordersIschemic Heart Disease
Heart Care Foundation6,000 enrolled196 locationsNCT06275113
Recruiting
Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis
Head and Neck Cancer
Centro di Riferimento Oncologico - Aviano953 enrolled10 locationsNCT05817617
Recruiting
Phase 3
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Diffuse Large B Cell LymphomaElderly Patients
Fondazione Italiana Linfomi - ETS430 enrolled49 locationsNCT04442412